Dr. Reddy's debuts generic HectorolHectorol injection single-dose vials and multidose vials brand and generics had a market value of approximately $138 million for the most recent 12 months ending in September 2019, according to IQVIA. Lupin launches generic potassium chloride oral solutionPotassium chloride for oral solution, 20 mEq, had a market value of roughly $90 million, according to IQVIA data from September 2019. Zydus Cadila gets tentative FDA nod for generic Otezla Zydus Cadila's generic Otezla provides a treatment for psoriatic arthritis, and mouth sores for people with Behcet's disease. FDA approves Pfizer's Humira biosimilar, offers update on progress biosimilar approvals Pfizer plans to launch Humira biosimilar in 2023. Study: USP quality standards support U.S. generics market Public quality standards set forth by USP increased competition in the generic medicines market and reduced overall prescription drug costs by $11 billion in 2015 and 2016. Fresenius Kabi introduces generic Emend Fresenius Kabi's generic Emend provides clinicians with a treatment alternative that has a 24-month shelf life. Breckenridge gets FDA green light for generic Tarceva Tarceva and its generics had a market value of approximately $145 million during the year ended Sept, 30, 2019. Teva taps Eli Kalif as executive vice president, CFO Eli Kalif will join Teva as executive vice president and chief financial officer on Dec. 22. Glenmark gets FDA nod for generic Epiduo Epiduo gel had a market value of about $33.7 million for the 12 month period ended September 2019, according to IQVIA. Fresenius Kabi launches small-volume prefilled heparin sodium syringes Fresenius Kabi is expanding its heparin and Simplist prefilled syringe portfolio with the addition of a small-volume presentation of Heparin. First Previous 155 156 157 158 159 Next Last